Reported Earlier, Carlsmed Prices $100.5M Initial Public Offering Of 6.7M Common Shares At $15 Per Share

The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Carlsmed, are expected to be approximately $100.5 million, excluding any exercise of the underwriters' option to purchase additional common stock.